PHILADELPHIA, July 29, 2024 (GLOBE NEWSWIRE) -- Attention Marinus Pharmaceuticals, Inc. (“Marinus” or the “Company”) (NASDAQ: MRNS) Investors. A securities fraud class action lawsuit has been filed against Marinus on behalf of purchasers of Marinus securities between March 17, 2021 and May 7, 2024, inclusive (the “Class Period”). CLICK HERE to learn more about the lawsuit. Important deadline: Investors who purchased or acquired Marinus securities during the Class Period may, no later than August 5, 2024, se ...